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FCεRI Gene Promoter Polymorphisms and Total IgE Levels in 
Susceptibility to Atopic Dermatitis in Korea
IgE-dependent activation of mast cells and basophils through the high-affinity IgE receptor 
(FcεRI) is involved in the pathogenesis of allergen-induced immune responsiveness in 
atopic diseases like atopic dermatitis (AD). We sought to determine FcεRI gene 
polymorphisms are associated with AD in Korean patients, and analyzed the relevance of 
FcεRI gene polymorphisms and serum IgE levels. We conducted a case-control association 
analysis (175 patients and 56 controls) of Korean subjects. Genotyping was performed 
using the TaqMan fluorogenic 5´ nuclease assay, and serum levels of IgE were measured 
using a fluorescence enzyme immunoassay. We found that there were no significant 
relationships between FcεRI and AD, although there were trends towards an association 
between the 66T>C (rs2251746) polymorphism and total serum IgE levels in the Korean AD 
patients. In conclusion, while the 66T>C (rs2251746) of the FcεRIα polymorphism may be 
linked to AD and higher serum IgE levels, polymorphisms in the FcεRIβ gene did not confer 
susceptibility to AD in our patient sample.
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INTRODUCTION
Atopic dermatitis (AD) is a common chronic inflammatory skin 
disease that, along with asthma and allergic rhinitis, forms the 
atopic triad (1). It is characterized by xerotic skin with pruritus 
and chronic inflammation (2). The cause of AD is still unknown, 
but there is evidence for complex interactions between genetic 
and environmental factors (3). Genetic factors have an impor-
tant influence on the risk of developing atopic disease, and sev-
eral genome-wide searches have provided evidence linking at-
opy to loci on multiple autosomal chromosomes (4).  
  High-affinity IgE receptor (FcεRI) is expressed mainly on the 
surfaces of mast cells, basophils, dendritic cells, Langerhans cells 
and monocytes (5-7). IgE-dependent activation of mast cells and 
basophils through the FcεRI is an initial step in the sequence of 
the atopic reaction (6-10). 
  FcεRI plays a central role in the induction and maintenance 
of allergic responses by mast cells and basophils. The β-chain  
of FcεRI plays a critical role in setting the level of the cellular re-
sponse to IgE and antigen through its capacity to amplify FcεRI 
signaling and cell surface expression (11). Several polymor-
phisms in the gene encoding the β-chain of the FcεRI (FcεRIβ) 
have been identified (12).
  FCεR1A is an important immunity-related gene that encodes 
the α-chain of FcεRI (13). Two FcεRIα single-nucleotide polymor-
phisms, -315aC>T (rs2427827) and -66aT>C (rs2251746) appear 
to be the only common genetic variants localized in a region of 
the proximal promoter in subjects of European descent (14, 15), 
and the only two variants present in that region in East Asians 
have been deemed functional (16-18). In this study, we focused 
on the two FcεRIα polymorphisms (-315C/T and -66T>C) and 
the two FcεRIβ polymorphisms (-211C/T and E237G) and per-
formed a genetic association study of susceptibility to atopic 
dermatitis in Korean subjects.
MATERIALS AND METHODS
Subjects
The present study included 175 patients with AD (80 males and 
95 females; mean age 9.18 ± 5.04 yr) and 56 healthy controls (30 
males and 26 females; mean age 10.78 ± 6.64 yr). Healthy con-
trols were individuals with serum total IgE levels within the nor-
mal range and without AD, allergic asthma, allergic rhinitis, atop-
ic keratoconjunctivitis or other allergic symptoms as determined 
by a questionnaire. People with present or past atopic disease, 
IgE-mediated sensitization or a family history of atopy and der-
matological diseases were excluded from the control group. All 
patients fulfilled the Hanifin and Rajka diagnostic criteria for AD 
(19). The baseline clinical characteristics of the Korean patients 
with AD are shown in Table 1. As previously described (20, 21), 
allocation to either the extrinsic (ADe) or intrinsic (ADi) AD phe-
notype subgroup was performed according to the presence of Park KY, et al.  •  FCεRI Gene Promoter Polymorphisms in Susceptibility to Atopic Dermatitis
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IgE-mediated sensitization as determined by fluorescence en-
zyme immunoassay analysis (FEIA) and skin prick test. 
 
Genotyping methods
The following four FCεR1 gene polymorphisms were typed: 
FCεR1A-95T/C (rs2251746), FCεR1A-344C>T (rs2427827), 
MS4A2-109T>C (rs1441586), and MS4A2 E237G (rs569108). All 
were described previously for a Korean sample (22).  
  Single nucleotide polymorphism (SNP) genotyping was per-
formed using the TaqMan fluorogenic 5´ nuclease assay (ABI, 
Foster City, CA, USA). Briefly, DNA samples were extracted from 
whole venous blood (G-DEX
TM Genomic DNA Extraction kits; 
iNtRON Biotechnology, Sungnam, Korea). The extracted DNA 
was quantified by spectrophotometer, and the quality of the DNA 
was determined by electrophoresis through an agarose gel and 
staining with ethidium bromide. The final volume of the poly-
merase chain reaction (PCR) was 5 μL, containing 10 ng of geno-
mic DNA and 2.5 μL of TaqMan Universal PCR Master Mix, with 
0.13 μL of 40 × Assay Mix (Assay ID C___1840470_20, RS2427827-
CT4, C___18422260_10, C___2684958_10; ABI). Thermal cycle 
conditions were as follows: 50°C for 2 min to activate uracil N-
glycosylase and to prevent carry-over contamination, 95°C for 
10 min to activate DNA polymerase followed by 45 cycles of 95°C 
for 15 sec and 60°C for 1 min. All PCR reactions were performed 
using 384-well plates in a Dual 384-Well GeneAmp PCR System 
9700 (ABI), and the endpoint fluorescent readings were per-
formed on an ABI PRISM 7900 HT Sequence Detection System 
(ABI). Duplicate samples and negative controls were included 
to ensure genotyping accuracy.
 
Statistical analysis
Statistical analyses comparing the allele and genotype distribu-
tions were performed using chi-square or Fisher’s exact tests. 
Odds ratios (ORs) and 95% confidence intervals (CIs) were cal-
culated according to Woolf’s method, using SPSS 10.0 software 
for Windows (SPSS, Chicago, IL, USA). P < 0.05 was considered 
statistically significant. Linkage disequilibrium pairwise values 
were obtained using Haploview software (Broad Institute, Cam-
bridge, MA, USA).
 
Ethics statement
The study protocol was approved by the institutional review 
board of the Chung-Ang University Hospital Institute Review 
Board (C2008030/133). Informed consent was obtained from 
all subjects. All investigations were conducted according to the 
principles of the Declaration of Helsinki.
RESULTS
The distribution of the -315C>T (rs2427827) variant
No associations were observed between the -315C>T (rs2427827) 
polymorphism and the log10-transformed total serum IgE levels 
in the AD patients in the genotype model (CC vs CT vs TT; 1.97 
± 0.68 vs 2.17 ± 0.61 vs 2.7 ± 0.9, mean ± SD; P = 0.089, unpaired 
Student’s t-test) or the dominant model (1.97 ± 0.68 vs 2.21 ± 0.65; 
P = 0.078). Recessive and allelic models were not tested because 
of the very low frequency of -315C>T homozygotes. A compari-
son of healthy subjects with the entire group of AD patients (n = 
175), yielded the following results: CC vs CT vs TT (genotype 
model) (Table 2), P = 0.36 (chi-square test); CC vs CT + TT (dom-
inant model), P = 0.22 (two-tailed Fisher exact test); CC + CT vs 
TT (recessive model), P = 0.6 (two-tailed Fisher exact test); C vs 
T (allelic model), P = 0.16 (two-tailed Fisher exact test) (Table 1). 
A comparison of the ADe and ADi groups yielded the following 
results: CC vs CT vs TT (genotype model), P = 0.66 (chi-square 
test); CC vs CT + TT (dominant model), P = 0.42 (two-tailed Fish-
er exact test); CC + CT vs TT (recessive model), P = 1.0 (two-tailed 
Fisher exact test); C vs T (allelic model), P = 0.371 (two-tailed 
Fisher exact test) (data not shown). 
The distribution of the -66T>C (rs2251746) variant
We detected associations between the -66T>C (rs2251746) poly-
morphism and the log10-transformed total serum IgE levels in 
the AD patients in a dominant model (TT vs CT + CC; 2.09 ± 0.67 
vs 1.82 ± 0.69, mean ± SD; P = 0.026, unpaired Student’s t-test). 
Recessive and genotype models were not tested because of the 
very low frequency of -66CC homozygotes. A comparison of 
healthy subjects and the entire group of AD patients yielded the 
following results: TT vs CT vs CC (genotype model), P = 0.02 (chi-
square test); TT vs CT + CC (dominant model), P = 0.07 (two-tailed 
Fisher exact test); TT + CT vs CC (recessive model), P = 0.25 (two-
tailed Fisher exact test); T vs C (allelic model), P = 0.22 (two-tailed 
Fisher exact test) (Table 3). A comparison of the ADe and ADi 
Table 1. Clinical and serological characteristics of Korean patients with atopic der-
matitis
Parameters Findings
Gender (M/F), No. (%) 80 (45.7)/95 (54.3%)
Age (yr)  9.18 ± 5.04
Mean IgE (kU/L)    836.44 ± 1038.37
EASI (0-72), median 9
IGA (0-5), mean 3
VAS (0-10) 6.77 ± 3.14
Data are mean ± SD unless otherwisw indicated. EASI, Eczema Area and Severity 
Index; IGA,Investigator Global Assessment; VAS,visual analogue scale.
Table 2. Analysis of the FcεRIa gene (FCER1A) -315C>T (rs2427837) polymorphism
Group of subjects
Genotype frequency, No. (%)
Total
CC CT TT
Healthy subjects    33 (59.5) 20 (35.1) 3 (5.4)   56 (100)
AD, IgE ≤ 1000 64 (75) 20 (23.2) 1 (1.8)   85 (100)
AD, IgE > 1000    61 (67.8) 26 (28.8) 3 (3.4)   90 (100)
Total  158 (68.4) 66 (28.3) 7 (3.3) 231 (100)Park KY, et al.  •  FCεRI Gene Promoter Polymorphisms in Susceptibility to Atopic Dermatitis
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groups yielded the following results: TT vs CT vs CC (genotype 
model), P = 0.8 (chi-square test); TT vs CT + CC (dominant mod-
el), P = 0.8 (two-tailed Fisher exact test); T vs C (allelic model), P 
= 0.64 (two-tailed Fisher exact test). 
The distribution of the -211 C>T (rs1441586) variant
No associations were observed between the -211 C>T (rs1441586) 
polymorphism and the log10-transformed total serum IgE levels 
in the AD patients in either the genotype model (TT vs CT vs 
CC; 2.04 ± 0.68 vs 2.03 ± 0.66 vs 2.06 ± 0.66, mean ± SD; P = 0.989, 
unpaired Student’s t-test) or the dominant model (1.97 ± 0.68 vs 
2.21 ± 0.65; P = 0.078). A comparison of healthy subjects and the 
AD patients yielded the following results: TT vs CT vs CC (geno-
type model), P = 0.379 (chi-square test); TT vs CT + CC (domi-
nant model), P = 0.706 (two-tailed Fisher exact test); TT + CT vs 
CC (recessive model), P = 0.243 (two-tailed Fisher exact test); T 
vs C (allelic model), P = 0.258 (two-tailed Fisher exact test) (Table 
4). A comparison of the ADe and ADi groups yielded the follow-
ing results: TT vs CT vs CC (genotype model), P = 0.871 (chi-
square test); TT vs CT + CC (dominant model), P = 0.71 (two-
tailed Fisher exact test); TT + CT vs CC (recessive model), P = 
0.790 (two-tailed Fisher exact test); T vs C (allelic model), P = 
0.781 (two-tailed Fisher exact test). 
The distribution of the E237G (rs569108) variant
No associations were observed between the -E237G (rs569108) 
polymorphism and the log10-transformed total serum IgE levels 
in the AD patients in either the genotype model (AA vs GA vs 
GG; 1.97 ± 0.67 vs 2.26 ± 0.71 vs 1.83 ± 0.49, mean ± SD; P = 0.11, 
unpaired Student’s t-test) or the dominant model (1.97 ± 0.67 vs 
2.19 ± 0.70; P = 0.121). A comparison of the healthy subjects and 
the AD patients yielded the following results: AA vs GA vs GG 
(genotype model), P = 0.753 (chi-square test); AA vs GA + GG 
(dominant model), P = 0.675 (two-tailed Fisher exact test); AA + 
GA vs GG (recessive model), P = 1.0 (two-tailed Fisher exact test); 
A vs G (allelic model), P = 0.477 (two-tailed Fisher exact test) 
(Table 5). A comparison of the ADe and ADi groups yielded the 
following results: AA vs GA vs GG (genotype model), P = 0.484 
(chi-square test); AA vs GA + GG (dominant model), P = 0.691 
(two-tailed Fisher exact test); AA + GA vs GG (recessive model), 
P = 0.431 (two-tailed Fisher exact test); A vs G (allelic model), P = 
1.0 (two-tailed Fisher exact test). 
DISCUSSION
AD is a chronic skin disease that affects more than 15% of chil-
dren and 2% of adults. Strong connections between genetic fac-
tors and AD have been described in the literature. AD is associ-
ated with the later development of allergic asthma and rhino-
conjunctivitis in approximately 30%-70% of affected individuals 
(23). AD and other atopic diseases share pathogenic and immu-
nological features, such as elevated total serum IgE and allergen-
specific IgE levels. However, the role of IgE in AD still remains 
unclear (24). Kim et al. (25) indicated that the distribution of the 
genotype and allele frequencies of the FcεRIβ -109T/C polymor-
phism is significantly associated with asthma and elevated se-
rum IgE levels. Niwa et al. (26) recently analyzed two promoter 
polymorphisms of the FcεRIa gene ([FcεRIa], -66T>C [rs2251746] 
and -315C>T [rs2427827]) in Japanese atopic dermatitis subjects 
and reported that patients with the -315CT⁄TT genotype tended 
to have higher total serum IgE levels, while the proportion of the 
-315CT⁄TT genotype or the -315T allele was significantly higher 
in those with highly elevated total serum IgE. Unlike previous 
studies, the present study detected no significant differences in 
allele and genotype frequencies of the four FcεRI polymorphisms 
between the AD patients and the healthy subjects (Table 2). There 
were more carriers of the -315C allele among the AD patients 
than among the healthy subjects, but the difference was not sta-
tistically significant. The distributions of all four of the variants 
did not differ in the ADi patients or in the ADe patients in all test-
ed models. Notably, the distribution of the -66T>C (rs2251746) 
variant was different between the AD patients and the healthy 
controls in a genotype model (P = 0.022, chi-square test). How-
ever, it did not statistically differ in other tested models, an ob-
servation similar to previous findings (16, 26) The distribution 
of total serum IgE levels in the AD patients was approximated 
to normal by log10-transformation. There was a trend indicating 
a relationship between the -66T>C (rs2251746) polymorphism 
Table 3. Analysis of the FcεRIa gene (FCER1A) -66T>C (rs2251746) polymorphism
Group of subjects
Genotype frequency, No. (%)
Total
CC CT TT
Healthy subjects    1 (1.8) 1 (1.8)   54 (96.4)   56 (100)
AD, IgE ≤ 1,000 0 (0) 15 (18.1)   68 (81.9)   83 (100)
AD, IgE > 1,000 0 (0) 14 (15.4)   77 (84.6)   91 (100)
Total    1 (0.4) 30 (13.1) 199 (86.5) 230 (100)
Table 4. Analysis of the FcεRIb gene (FCER1B) -211 C>T (rs1441586) polymorphism
Group of subjects
Genotype frequency, No. (%)
Total
CC CT TT
Healthy subjects      3 (5.4) 26 (46.4)   27 (48.2)   56 (100)
AD, IgE ≤ 1,000      11 (12.9) 35 (41.2)   39 (45.9)   85 (100)
AD, IgE > 1,000 14 (0) 38 (42.2)   38 (42.2)   90 (100)
Total      28 (12.1) 99 (42.9) 104 (45.0) 231 (100)
Table 5. Analysis of the FcεRIb gene (FCER1B) E237G (rs569108) polymorphism
Group of subjects
Genotype frequency, No. (%)
Total
AA GA GG
Healthy subjects   41 (75.0) 12 (22.2) 2 (2.8)   55 (100)
AD, IgE ≤ 1,000   61 (71.4) 18 (21.4) 6 (7.1)   85 (100)
AD, IgE > 1,000   61 (67.8) 26 (28.8) 3 (3.4)   90 (100)
Total 107 (74.6) 37 (21.8) 7 (3.6) 230 (100)Park KY, et al.  •  FCεRI Gene Promoter Polymorphisms in Susceptibility to Atopic Dermatitis
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and the log10-transformed total serum IgE levels in the AD pa-
tients in a dominant model (TT vs CT + CC; 2.09 ± 0.67 vs 1.82 ± 
0.69, mean ± SD; P = 0.026, unpaired Student’s t-test). However, 
neither the number of -66C allele carriers (P = 0.067, two-tailed 
Fisher exact test) nor the frequency of the -66C allele (P = 0.217, 
two-tailed Fisher exact test) were significantly different between 
the AD patients with total serum IgE levels > 1,000 IU⁄mL and 
those having total serum IgE concentrations ≤ 1,000 IU⁄mL (Ta-
ble 2). No significant relationships were observed between the 
other polymorphisms (-315C>T, -211C>T and E237G) and the 
log10-transformed total serum IgE levels in the AD patients. Our 
findings are not consistent with observations by Potaczek et al. 
(15), Bae et al. (17) or Hizawa et al. (27), who reported that the 
FCER1A -315C>T promoter polymorphism and FCER1B genetic 
variants (-E237G and -109T>C) were associated with total serum 
IgE concentrations in allergic patients. However, our observation 
of an association between higher total serum IgE levels and the 
-66T>C (rs2251746) polymorphism in AD patients concurs with 
previous reports by Hasegawa et al. (16). They suggested that in 
a Japanese sample, a statistically significant portion of non-aller-
gic individuals had a heterozygous -66T/C genotype, while most 
of the allergic individuals had a homozygous -66T/T genotype.
  Here we studied the relationship between the FCER1A,B genes 
and susceptibility to AD in a group of Korean subjects. To our 
knowledge, this is the first study of the relationship between 
FCER1A,B and AD in a Korean sample. Our overall data showed 
no association between FcεRI and AD, although these results 
may be affected by factors such as genetic background, statisti-
cal method, and sample size. In short, according to the findings 
of the present study, polymorphisms in the FcεRIβ gene do not 
confer susceptibility to AD in Korean patients, while the 66T>C 
(rs2251746) variant of the FcεRIα polymorphism may be linked 
to AD and higher serum IgE levels.
  We hypothesize that some discrepancies between our results 
and the above-mentioned studies may be ascribed to the differ-
ent origins of the samples analyzed: Polish, Japanese and Amer-
ican. The heterogeneity of American and Polish subjects may be 
a reason for the differences between our results and those found 
by Shikanai et al. (14) and Potaczek et al. (15). As a similar exam-
ple, filaggrin null mutations, which are known for their relevance 
in atopy, also exhibit population and regional diversity (28-30). 
Another possible explanation for the differences between our 
findings and those of other studies may be the small number of 
patients analyzed in our study, which was 175. If a relationship 
between a SNP and clinical phenotype was found in a small num-
ber of patients, this indicates a very strong association. However, 
only trends towards an association between the -66T>C (rs22-
51746) polymorphism and total serum IgE levels in the Korean 
AD patients were observed. We therefore plan to conduct a more 
extensive study on two FCER1A loci, the -66T>C (rs2251746) poly-
morphism that trended towards an association with total serum 
IgE levels in the Korean AD patients. The -315C>T (rs 2427827) 
polymorphism was recently analyzed in Japan. This proposed 
study will include a larger number of patients and will also ana-
lyze AD severity, family history, and other clinical aspects. 
  The present study emphasized the importance of the FCER 
polymorphism and AD in disease association studies across pop-
ulations. Further studies of the possible disease-modifying ef-
fect of the FCER gene polymorphisms on AD patients are war-
ranted.
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IgE-dependent activation of mast cells and basophils through the high-affinity IgE receptor (FcεRI) is involved in the pathogenesis 
of allergen-induced immune responsiveness in atopic diseases like atopic dermatitis. We sought to determine FcεRI gene 
polymorphisms are associated with AD in Korean patients, and analyzed the relevance of FcεRI gene polymorphisms and serum IgE 
levels. We conducted a case-control association analysis (175 patients and 56 controls) of South Korean subjects. Genotyping was 
performed using the TaqMan fluorogenic 5’ nuclease assay, and serum levels of IgE were measured using a fluorescence enzyme 
immunoassay analysis. We found that there were no significant relationships between FcεRI and AD, although there were trends 
towards an association between the 66T>C (rs2251746) polymorphism and total serum IgE levels in the Korean AD patients. In 
conclusion, while the 66T>C (rs2251746) of the FcεRIα polymorphism may be linked to AD and higher serum IgE levels, 
polymorphisms in the FcεRIβ gene did not confer susceptibility to AD in our patient sample.